Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 11 (Search time: 0.002 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2014Interactions between inflammatory activation and endothelial dysfunction selectively modulate valve disease progression in patients with bicuspid aortic valveAli, O.; Chapman, M.; Thanh, H.; Chirkov, Y.; Heresztyn, T.; Mundisugih, J.; Horowitz, J.
2018Asymmetric and symmetric dimethylarginine predict outcomes in patients with atrial fibrillation: an ARISTOTLE substudyHorowitz, J.; De Caterina, R.; Heresztyn, T.; Alexander, J.; Andersson, U.; Lopes, R.; Steg, P.; Hylek, E.; Mohan, P.; Hanna, M.; Jansky, P.; Granger, C.; Wallentin, L.
2011Determinants of insulin responsiveness in young women: Impact of polycystic ovarian syndrome, nitric oxide, and vitamin DNgo, D.; Chan, W.; Rajendran, S.; Heresztyn, T.; Amarasekera, A.; Sverdlov, A.; O'Loughlin, P.; Morris, H.; Chirkov, Y.; Norman, R.; Horowitz, J.
2012Ramipril sensitizes platelets to nitric oxide: Implications for therapy in high-risk patientsWilloughby, S.; Rajendran, S.; Chan, W.; Procter, N.; Leslie, S.; Liberts, E.; Heresztyn, T.; Chirkov, Y.; Horowitz, J.
2013Enhanced NO signaling in patients with Takotsubo cardiomyopathy: short-term pain, long-term gain?Nguyen, T.; Neil, C.; Sverdlov, A.; Ngo, D.; Chan, W.; Heresztyn, T.; Chirkov, Y.; Tsikas, D.; Frenneaux, M.; Horowitz, J.
2011The endogenous NOS inhibitor asymmetric dimethylarginine (ADMA) predicts LV mass independent of afterloadSverdlov, A.; Ngo, D.; Nightingale, A.; Rajendran, S.; Mishra, K.; Heresztyn, T.; Ritchie, R.; Marwick, T.; Frenneaux, M.; Horowitz, J.
2013Premature aging of cardiovascular/platelet function in polycystic ovarian syndromeChan, W.; Ngo, D.; Sverdlov, A.; Rajendran, S.; Stafford, I.; Heresztyn, T.; Chirkov, Y.; Horowitz, J.
2011Lack of association between aortic sclerosis and left ventricular hypertrophy in elderly subjectsNightingale, A.; Sverdlov, A.; Rajendran, S.; Mishra, K.; Heresztyn, T.; Ngo, D.; Horowitz, J.
2017Early use of N-acetylcysteine with nitrate therapy in patients undergoing primary percutaneous coronary intervention for ST-segment-elevation myocardial infarction reduces myocardial infarct size (the NACIAM trial [N-acetylcysteine in acute myocardial infarction])Pasupathy, S.; Tavella, R.; Grover, S.; Raman, B.; Procter, N.; Du, Y.; Mahadavan, G.; Stafford, I.; Heresztyn, T.; Holmes, A.; Zeitz, C.; Arstall, M.; Selvanayagam, J.; Horowitz, J.; Beltrame, J.
2015Impaired platelet nitric oxide response in patients with new onset atrial fibrillationProcter, N.; Ball, J.; Liu, S.; Hurst, N.; Nooney, V.; Goh, V.; Stafford, I.; Heresztyn, T.; Carrington, M.; Ngo, D.; Hylek, E.; Isenberg, J.; Chirkov, Y.; Stewart, S.; Horowitz, J.